Aveanna Healthcare (NASDAQ:AVAH) CEO Sells 173,225 Shares

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) CEO Jeff Shaner sold 173,225 shares of Aveanna Healthcare stock in a transaction on Thursday, February 19th. The stock was sold at an average price of $7.21, for a total value of $1,248,952.25. Following the sale, the chief executive officer directly owned 2,650,892 shares of the company’s stock, valued at approximately $19,112,931.32. This trade represents a 6.13% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.

Jeff Shaner also recently made the following trade(s):

• On Wednesday, February 18th, Jeff Shaner sold 168,800 shares of Aveanna Healthcare stock. The shares were sold at an average price of $7.38, for a total value of $1,245,744.00.
• On Tuesday, February 17th, Jeff Shaner sold 119,884 shares of Aveanna Healthcare stock. The stock was sold at an average price of $7.65, for a total value of $917,112.60.
• On Friday, January 2nd, Jeff Shaner sold 29,357 shares of Aveanna Healthcare stock. The shares were sold at an average price of $7.85, for a total value of $230,452.45.
• On Wednesday, December 31st, Jeff Shaner sold 27,674 shares of Aveanna Healthcare stock. The shares were sold at an average price of $8.18, for a total transaction of $226,373.32.
• On Tuesday, December 30th, Jeff Shaner sold 27,929 shares of Aveanna Healthcare stock. The stock was sold at an average price of $8.36, for a total transaction of $233,486.44.

Aveanna Healthcare Trading Up 0.3%

NASDAQ:AVAH traded up $0.02 during trading hours on Thursday, hitting $7.42. The stock had a trading volume of 3,877,110 shares, compared to its average volume of 938,081. Aveanna Healthcare Holdings Inc. has a one year low of $3.67 and a one year high of $10.32. The company has a debt-to-equity ratio of 140.39, a quick ratio of 1.23 and a current ratio of 1.23. The company has a market cap of $1.55 billion, a price-to-earnings ratio of 20.61 and a beta of 2.06. The business’s 50 day moving average is $8.48 and its 200-day moving average is $8.44.

Institutional Inflows and Outflows

A number of hedge funds have recently modified their holdings of AVAH. Quantbot Technologies LP bought a new stake in Aveanna Healthcare in the 2nd quarter valued at approximately $43,000. MQS Management LLC bought a new stake in shares of Aveanna Healthcare in the second quarter worth $59,000. Belvedere Trading LLC bought a new stake in shares of Aveanna Healthcare in the second quarter worth $62,000. Oxford Asset Management LLP acquired a new position in Aveanna Healthcare during the second quarter worth $64,000. Finally, Dynamic Technology Lab Private Ltd bought a new position in Aveanna Healthcare in the second quarter valued at $68,000. 87.96% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

Several research analysts have weighed in on the company. Weiss Ratings reiterated a “hold (c+)” rating on shares of Aveanna Healthcare in a report on Monday, December 29th. Zacks Research lowered Aveanna Healthcare from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, February 3rd. Truist Financial lifted their price objective on Aveanna Healthcare from $9.50 to $10.00 and gave the company a “hold” rating in a report on Friday, November 7th. Royal Bank Of Canada boosted their price objective on Aveanna Healthcare from $10.00 to $11.00 and gave the company a “sector perform” rating in a research report on Thursday, January 15th. Finally, Barclays increased their target price on Aveanna Healthcare from $9.00 to $11.00 and gave the stock an “overweight” rating in a research note on Friday, January 16th. Five research analysts have rated the stock with a Buy rating and six have given a Hold rating to the company. According to MarketBeat, Aveanna Healthcare currently has an average rating of “Hold” and an average price target of $11.06.

Aveanna Healthcare Company Profile

Aveanna Healthcare, Inc (NASDAQ: AVAH) is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna’s offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.

In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.